Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations. 2007

Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
Institute of Medical Virology, University Hospital, Frankfurt/Main, Paul-Ehrlich-Str. 40, 60596 Frankfurt/Main, Germany. rabenau@em.uni-frankfurt.de

Measles virus infection as well as measles vaccination induces a long-lasting immune protection. Specific antibodies have been proven to be associated with this immune protection, since measles immunity can be transferred by immune globulin application (passive immunisation). The neutralisation test (NT) is regarded as the gold standard method for measles immunity because it measures functional neutralising antibody, while with the ELISA, which is often based on cell culture grown native virus antigens, predominantly antibodies to the nucleoprotein antigen were detected. To compare the results of NT and ELISA 199 individual sera and 364 gamma globulin samples, which were made from plasma pools, were tested. Qualitative results showed that the sensitivity of the ELISA was 141/144 (97.9%) and specificity was 48/55 (87.3%) when compared to the NT and focused to the patient samples. For the gamma globulin samples the sensitivity and specificity was 100%. As expected no measles NT negative plasma pool samples were found. The present study showed that with increasing NT-titre, the ELISA-values also rise. False negative ELISA results were obtained in 1.5% of patient sera, mainly containing low levels of neutralising antibody. In both antibody tests seropositive specimens revealed a quite good to moderate correlation. Taken together, the measles IgG ELISA is adequately for immunity testing and identifying of seronegative individuals for vaccination.

UI MeSH Term Description Entries
D008297 Male Males
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
October 1986, Journal of medical virology,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
January 1965, Public health reports (Washington, D.C. : 1896),
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
February 1967, The Medical journal of Australia,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
December 1992, Transplantation,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
October 1963, Science (New York, N.Y.),
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
September 1985, Gastroenterology,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
January 1992, Advances in experimental medicine and biology,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
January 2019, Voprosy virusologii,
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
January 1963, Journal of immunology (Baltimore, Md. : 1950),
Holger F Rabenau, and Branko Marianov, and Sabine Wicker, and Regina Allwinn
September 1965, American journal of epidemiology,
Copied contents to your clipboard!